ResultsCNBC-TV18
Gland Pharma Q2 profit jumps 58% to Rs 291 crore
GreyOak summary
Gland Pharma reported a 58.2% year-on-year increase in net profit to ₹291 crore for Q2 FY27, driven by strong business execution. Revenue rose 23.3% to ₹1,834 crore, with CDMO revenue growing 31%. The company launched four molecules in the US and continues expanding its complex injectables pipeline.
What it affects
- Gland PharmaGLANDPositive +23
Net profit jumped 58% to ₹291 croreRolling sentiment Positive +64
Source
Read the original at CNBC-TV18More Gland Pharma news
- Five Stocks To Buy Today, November 11: Gland Pharma, Sansera Engineering, Union Bank, And MoreNDTV Profit · Stock view ·
- Gland Pharma shares rally 8% to hit 4-year-high post strong Q2Moneycontrol · Results ·
- Gland Pharma shares jump 7% to 52-week highCNBC-TV18 · Stock view ·
- Pharma shares shine: Sai, Gland, Divi's, Laurus, Glenmark surge up to 9%Business Standard · Stock view ·
- Divis, Gland, Sai Life Sciences shares hit 52-week highsBusiness Today · Stock view ·